FKF1 inhibitors constitute a well-defined and intriguing chemical class that has gained prominence within the sphere of biochemical exploration. This class of compounds is intricately tailored to exert a targeted modulatory influence over the intricate functionality of the FKF1 protein. The acronym "FKF1" denotes "FLAVIN-BINDING, KELCH REPEAT, F-BOX 1," a pivotal protein integral to the orchestration of the circadian clock machinery inherent to plants. This protein assumes a cardinal role in the oversight of diverse physiological processes, prominently encompassing the temporal coordination of pivotal developmental milestones, most notably the flowering process.
A central facet of FKF1's functioning lies in its capacity to function as a photo-receptor, predominantly attuned to the perception of blue light wavelengths. This light-sensing ability translates into its profound involvement in the transduction of luminous stimuli into a cascade of intricate molecular responses. The chemical entities classified as FKF1 inhibitors are meticulously architected compounds, strategically tailored to establish a specific interaction with FKF1. This interaction is characterized by its propensity to disrupt the normative conduction of FKF1's regulatory role. Precise binding to distinct loci on the FKF1 protein engenders a derailing effect on its capacity to faithfully relay luminous cues, consequently reverberating into a modulation of downstream signal transduction pathways. The meticulous scrutiny of FKF1 inhibitors unfurls a treasure trove of insights into the labyrinthine tapestry of mechanisms governing circadian rhythm harmonization and light-responsive physiological retorts intrinsic to the plant kingdom.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $76.00 $148.00 | 9 | |
FK506 is a well-known immunosuppressive drug that forms a complex with FKBP12, inhibiting calcineurin and ultimately suppressing T-cell activation and immune response. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin is an immunosuppressive drug that also binds to FKBPThe FKBP12-rapamycin complex inhibits the mTOR (mammalian target of rapamycin) pathway, leading to reduced cell growth and proliferation. | ||||||
Ascomycin | 104987-12-4 | sc-207303B sc-207303 sc-207303A | 1 mg 5 mg 25 mg | $36.00 $173.00 $316.00 | ||
Ascomycin binds to FKBP12 and suppresses immune responses by inhibiting calcineurin. It has been investigated for its potential use in immunosuppression. | ||||||
Apilimod | 541550-19-0 | sc-480051 sc-480051A | 100 mg 1 g | $420.00 $2600.00 | 5 | |
Apilimod is an investigational drug that targets various immune signaling pathways. It binds to FKBP12 and affects interleukin-12 (IL-12) and interleukin-23 (IL-23) signaling. | ||||||
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $128.00 $638.00 | 7 | |
Everolimus is an mTOR inhibitor that binds to FKBPIt. | ||||||